Entries by
Save the Date & Call for Abstracts
4-6 April 2023 / Nijmegen, the Netherlands The transition towards sustainable pharmaceuticals – assessing sustainability from design & production to prescription & use The IHI- & EU-funded research projects PREMIER and TransPharm are organising a joint workshop. The workshop is invitation-only. We encourage interested parties to submit abstracts for platform and/or poster presentations related […]
PREMIER partners present at SETAC North America 43rd Annual meeting – Don´t miss out our poster!
After three years without physical face-to-face meetings, SETAC finally had its North America 43rd Annual Meeting in Pittsburgh, Pennsylvania on the 13-17 November 2023. This year, the theme of the meeting was “Bridging Innovation and Sustainability.” It was a hybrid meeting with virtual presentations, innovative poster designs and, finally again, in-person talks, which were […]
PREMIER celebrates its 5th GAM and first face-to-face meeting!
Our fifth general assembly meeting (GAM#5) took place on the 4-6th of October 2022 in Milan. This was an important milestone for the project, where consortium partners and scientific advisory members were able to share and celebrate the progress made during the firsts 2 years of the project. This was also an excellent opportunity to […]
PREMIER partners publish GREENER criteria for the development of sustainable pharmaceuticals
This is the second scientific publication in PREMIER and represents a clear example of the success of this public-private partnership. The work has been published in Environmental, Scientific and Technology Letters and it was authored by public partners at RIVM, Leuphana University and the University of Exeter and industry partners AstraZeneca and GSK. Due […]
PREMIER publishes its first scientific paper: Development of a generalised physiologically based kinetic (PBK) model for fish
By Jiaqi (Fiona) Wang, PhD researcher in Environmental Science at Radboud University (Nijmegen, The Netherlands) Pharmaceuticals have been detected as emerging pollutants in global water bodies, potentially affecting aquatic organisms such as fish. Physiologically based kinetic (PBK) models can predict the active pharmaceutical ingredients (API) uptake, distribution, metabolism and excretion of fish and estimate API […]
Meet our Scientific Advisory Board: Interview with Despo Fatta-Kassinos
Despo Fatta-Kassinos is a Professor in the Department of Civil and Environmental Engineering of the University of Cyprus and Director of the Nireas International Water Research Center. What is your field of expertise? I am a Chemical Engineer with further studies in Environmental Science, Management and Engineering. My main research focuses on the understanding […]
PREMIER partners will present at SETAC Europe: don´t miss out!
The society of Environmental Toxicology and Chemistry (SETAC) celebrates its 32nd European Annual Meeting. This year will take place on the 15-19th May in Copenhagen, Denmark and online. The event is getting closer and the PREMIER partners are preparing to present some of the results produced during the project. A variety of PREMIER partners from […]
Meet our Scientific Advisory Board: Interview with Marlene Ågerstrand
Marlene Ågerstrand is an Assistant Professor at the Department of Environmental Science of Stockholm University. What is your field of expertise? My research focuses on understanding science-policy interactions in risk assessment and management of chemicals. Aspects of interest include the evaluation and use of data for decision-making, the efficiency of management options, and the […]
Exploring the feasibility of implementing the design of greener Active Pharmaceutical Ingredients by interviewing experts from pharma industry
By Neele Puhlmann, PhD candidate at Leuphana University Lüneburg, Rodrigo Vidaurre from Ecologic Institute and Prof. Klaus Kümmerer from Leuphana University Lüneburg, all WP4 contributors. Drug discovery and development experts of seven major pharmaceutical companies were interviewed by PREMIER members to explore the opportunities of incorporating environmental considerations into the pharmaceutical R&D process. The interviews […]
